Literature DB >> 16757526

Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.

Catherine E Hamelin1, Greg Anglin, Charmian A Quigley, Cheri L Deal.   

Abstract

CONTEXT: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X(maternal) and 45,X(paternal) individuals. OBJECTIVE AND
DESIGN: We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height. METHODS AND
RESULTS: Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an X(maternal), whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact X(paternal). No significant differences were noted between X(maternal) and X(paternal) subjects for parents' heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with X(maternal), baseline height sd score correlated with midparental height (all: r = 0.511, P < 0.001; X(maternal): r = 0.535, P = 0.001) and with mother's height (all: r = 0.510, P < 0.001; X(maternal): r = 0.574, P < 0.001) but only weakly with father's height (all: r = 0.334, P = 0.015; X(maternal): r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with X(maternal) had a greater mean height gain than those with X(paternal) (sd score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04-0.82, P = 0.030, and for 45,X was +0.64 and 0.06-1.21, P = 0.031); X-linked imprinting explained 36-53% of the GH response. After pure tone audiometry testing, X(maternal) subjects were also less likely (P = 0.040) to have sensorineural hearing loss than X(paternal) subjects.
CONCLUSION: This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757526     DOI: 10.1210/jc.2006-0490

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Abnormal motor cortex excitability is associated with reduced cortical thickness in X monosomy.

Authors:  Jean-François Lepage; Cédric Clouchoux; Maryse Lassonde; Alan C Evans; Cheri L Deal; Hugo Théoret
Journal:  Hum Brain Mapp       Date:  2011-11-18       Impact factor: 5.038

Review 2.  Child health, developmental plasticity, and epigenetic programming.

Authors:  Z Hochberg; R Feil; M Constancia; M Fraga; C Junien; J-C Carel; P Boileau; Y Le Bouc; C L Deal; K Lillycrop; R Scharfmann; A Sheppard; M Skinner; M Szyf; R A Waterland; D J Waxman; E Whitelaw; K Ong; K Albertsson-Wikland
Journal:  Endocr Rev       Date:  2010-10-22       Impact factor: 19.871

3.  The physical phenotype of girls and women with Turner syndrome is not X-imprinted.

Authors:  Carolyn A Bondy; Lea Ann Matura; Nicole Wooten; James Troendle; Andrew R Zinn; Vladimir K Bakalov
Journal:  Hum Genet       Date:  2007-01-23       Impact factor: 4.132

4.  Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome.

Authors:  Marsha L Davenport; Jackson Roush; Chunhua Liu; Anthony J Zagar; Erica Eugster; Sharon Travers; Patricia Y Fechner; Charmian A Quigley
Journal:  Horm Res Paediatr       Date:  2010-04-27       Impact factor: 2.852

5.  Parent of origin effects on age at colorectal cancer diagnosis.

Authors:  Noralane M Lindor; Kari G Rabe; Gloria M Petersen; Helen Chen; Bharati Bapat; John Hopper; Joanne Young; Mark Jenkins; John Potter; Polly Newcomb; Allyson Templeton; Loic Lemarchand; John Grove; Michael R Burgio; Robert Haile; Jane Green; Michael O Woods; Daniela Seminara; Paul J Limburg; Stephen N Thibodeau
Journal:  Int J Cancer       Date:  2010-07-15       Impact factor: 7.396

6.  High levels of education and employment among women with Turner syndrome.

Authors:  Harley N Gould; Vladimir K Bakalov; Carolyn Tankersley; Carolyn A Bondy
Journal:  J Womens Health (Larchmt)       Date:  2013-02-19       Impact factor: 2.681

Review 7.  Monosomy for the X chromosome.

Authors:  Carolyn A Bondy; Clara Cheng
Journal:  Chromosome Res       Date:  2009       Impact factor: 5.239

8.  Effects of X Chromosome Monosomy and Genomic Imprinting on Observational Markers of Social Anxiety in Prepubertal Girls with Turner Syndrome.

Authors:  Scott S Hall; Matthew J Riley; Robyn N Weston; Jean-Francois Lepage; David S Hong; Booil Jo; Joachim Hallmayer; Allan L Reiss
Journal:  J Autism Dev Disord       Date:  2021-03-09

9.  Recombinant human growth hormone in the treatment of Turner syndrome.

Authors:  Bessie E Spiliotis
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

10.  Effect of the parental origin of the X-chromosome on the clinical features, associated complications, the two-year-response to growth hormone (rhGH) and the biochemical profile in patients with turner syndrome.

Authors:  Francisco Alvarez-Nava; Roberto Lanes; José Miguel Quintero; Mirta Miras; Hugo Fideleff; Verónica Mericq; Henry Marcano; William Zabala; Marisol Soto; Tatiana Pardo; Lisbeth Borjas; Joalice Villalobos; Peter Gunczler; Nancy Unanue; Natalia Tkalenko; Adriana Boyanofsky; Liliana Silvano; Liliana Franchioni; Miriam Llano; Gabriel Fideleff; Miriam Azaretzky; Martha Suarez
Journal:  Int J Pediatr Endocrinol       Date:  2013-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.